The third Personalized Medicine World Conference, Silicon Valley, was held, appropriately, at the Computer History Museum in Mountain View, California. A pre-conference announcement from the organizers spoke of more than 800 attendees, but it must have been closer to 1,000 when I arrived in the afternoon on the first day. The conference was impressive in its scope, covering the gamut from science to regulatory to multiple facets of business. On the podium and in the audience, there was good representation of providers, payers, government, industry and patients (or at least patient advocacy). As a marketer, I’ll start with some takeaways for marketers from a diversity of sources.
If anyone ever doubts that healthcare is patient-centric, or that healthcare is moving toward a patient focus, think again. The focus on patients is here. This was illustrated by providers like Ralph Snyderman, MD, of Duke University, who spoke of a study that demonstrated dramatic improvements in adherence and reduction in costs in congested heart failure patients who received personalized care plans, intensive education and feedback loops. The theme was echoed by Vance Vanier, MD, whose genomics testing company, Navigenics, is partnering successfully with employers to make preventive medicine a reality in the workplace. Kathy L. Hudson, PhD, Chief of Staff, Office of the Director, National Institutes of Health (NIH), boldly envisions a future where everyone participates in personalized medicine and thinks “it’s cool.” And Leroy Hood, MD, PhD, of the Institute for Systems Biology spoke of the need to educate physicians and patients. Andrew Schorr of Patient Power, a master of ceremonies at PMWC 2011, hosted a session on patient empowerment.
The bottom line is that every marketing plan for a drug or diagnostic-related product needs to take into account the role of the patient or, more broadly, the consumer audience. Increased adherence to therapeutic, monitoring or self-monitoring regimens is a well-established rationale for educating and involving the patient. The power of patient advocacy in driving reimbursement or regulatory approval has been proven many times over. The propensity of patients and families to take ownership of becoming informed and pursuing treatment options in life-threatening, complex and/or chronic diseases such as cancer is another reason for including the patient in one’s marketing and communication plan. But there are other reasons. For example, an educated and engaged patient can contribute to care efficiency by making providers’ jobs a little easier. The healthcare system will see savings due to a decrease in unnecessary complications and emergency room visits. And above all, the transition from disease management to health management begins with preventive medicine and the educated and empowered consumer.